These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3006084)

  • 1. Urinary excretion of TXB2 after angiotensin converting enzyme inhibition in hypertensive patients.
    Kudo K; Abe K; Chiba S; Omata K; Sato K; Yasugima M; Sato M; Yoshinaga K
    Prostaglandins Leukot Med; 1986 Jan; 21(1):77-86. PubMed ID: 3006084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of sodium ferulate on hypotensive effect and urinary excretion of TXB2 after captopril in essential hypertensive patients].
    Xu XY; Wang Q
    Zhong Xi Yi Jie He Za Zhi; 1991 Nov; 11(11):657-8, 644. PubMed ID: 1667512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary observations of the acute effects of selective serum thromboxane inhibition and angiotensin converting enzyme inhibition on blood pressure and renal hemodynamics in hypertensive humans.
    Weir MR; Klassen DK; Hoover N; Douglas FL
    J Clin Pharmacol; 1989 Dec; 29(12):1108-16. PubMed ID: 2693500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of prostacyclin and thromboxane A2 metabolites after angiotensin converting enzyme inhibition in hypertensive patients.
    Vlasses PH; Ferguson RK; Smith JB; Rotmensch HH; Swanson BN
    Prostaglandins Leukot Med; 1983 Jun; 11(2):143-50. PubMed ID: 6308685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endogenous angiotensin II and prostaglandins in the antihypertensive mechanism of angiotensin converting enzyme inhibitor in hypertension.
    Omata K; Abe K; Tsunoda K; Yasujima M; Chiba S; Sato M; Kudo K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):569-74. PubMed ID: 3038419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
    Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
    Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of thromboxane A2 in the hypotensive effect of captopril in essential hypertension.
    Kudo K; Abe K; Chiba S; Sato M; Yasujima M; Kohzuki M; Omata K; Tanno M; Tsunoda K; Yoshinaga K
    Hypertension; 1988 Feb; 11(2):147-52. PubMed ID: 3277911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of captopril on urinary 6-keto-PGF1 alpha, thromboxane B2 in inbred SHR rats].
    Wang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):385-7, 398. PubMed ID: 1821358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
    Säynävälammi P
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary thromboxane B2 in hypertensive patients].
    Hornych A; Safar M; Bariéty J; Simon A; Krief C; Milliez P
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():109-13. PubMed ID: 6810812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats.
    Antonaccio MJ; Rubin B; Horovitz ZP; Laffan RJ; Goldberg ME; High JP; Harris DN; Zaidi I
    Jpn J Pharmacol; 1979 Apr; 29(2):285-94. PubMed ID: 231700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal synthesis of prostacyclin and thromboxane in healthy women: differential effects of a short-term saline loading.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 2000 Feb; 62(2):111-7. PubMed ID: 10780876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension.
    Abe K; Ito T; Sato M; Haruyama T; Sato K; Omata K; Hiwatari M; Sakurai Y; Imai Y; Yoshinaga K
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():141s-144s. PubMed ID: 7004721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.
    Moore TJ; Crantz FR; Hollenberg NK; Koletsky RJ; Leboff MS; Swartz SL; Levine L; Podolsky S; Dluhy RG; Williams GH
    Hypertension; 1981; 3(2):168-73. PubMed ID: 6260645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of delapril on renal function and urinary excretion of kallikrein, prostaglandin E2, and thromboxane B2 in hypertensive patients.
    Nishiyama K; Igari T; Nanba S; Ishii M
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):52S-53S. PubMed ID: 2009149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of captopril on urinary excretion of prostaglandins and electrolytes in spontaneously hypertensive rats.
    Miyamoto M; Koike H; Ito K; Yamazaki M
    Eur J Pharmacol; 1981 Dec; 76(2-3):187-92. PubMed ID: 7037429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous administration of a calcium antagonist on prostaglandins and thromboxane in plasma and urine in humans.
    Honda M; Manabe R; Minato M; Watanabe M; Fukuda N; Izumi Y; Hatano M
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):289-302. PubMed ID: 3532135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril enhances aminoglycoside nephrotoxicity in potassium-depleted rats.
    Klotman PE; Boatman JE; Volpp BD; Baker JD; Yarger WE
    Kidney Int; 1985 Aug; 28(2):118-27. PubMed ID: 2422431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.